摘要
为构建能稳定携带TAT-Apoptin融合基因的重组减毒鼠伤寒沙门菌,以pMD19-T-Apoptin为模板,PCR扩增出TAT-Apoptin融合基因,将其连接至pYA3493,构建了重组质粒pYA3493-TAT-Apoptin;然后将其电转至减毒鼠伤寒沙门菌SL1344ΔcrpΔasd,并对该重组减毒沙门菌的生长特性、遗传稳定性和表达特性进行了测定。PCR和测序结果表明,成功构建了重组质粒pYA3493-TAT-Apoptin。进一步对重组减毒鼠伤寒沙门菌SL1344ΔcrpΔasd(pYA3493-TAT-Apoptin)研究发现,其生长速度比强毒株SL1344明显减慢,与缺失株SL1344ΔcrpΔasd及互补菌株SL1344ΔcrpΔasd(pYA3493)基本一致,且能够稳定遗传TAT-Apoptin融合基因。重组菌培养上清经SDS-PAGE能检测到TAT-Apoptin蛋白条带。以上结果证明,能稳定携带TAT-Apoptin融合基因的重组减毒鼠伤寒沙门菌SL1344ΔcrpΔasd(pYA3493-TAT-Apoptin)构建成功,且该重组菌能分泌性表达TAT-Apoptin蛋白。
This study was aimed to construct a recombinant attenuated Salmonella enterica serovar Typhimurium strain for stable delivery of TAT-Apoptin fusion gene.Firstly,the TAT-Apoptin fusion gene was amplified from the recombinant plasmid pMD19-T-Apoptin by PCR,and inserted into the vector pYA3493.The recombinant plasmid pYA3493-TAT-Apoptin was electro-transformed into the attenuated S.entericaserovar Typhimurium SL1344ΔcrpΔasd.Then the growth characteristics,genetic stability and expression property of the recombinant attenuated S.enterica serovar Typhimurium SL1344ΔcrpΔasd(pYA3493-TAT-Apoptin)were analyzed.The results of PCR and sequencing showed that recombinant plasmid pYA3493-TAT-Apoptin was successfully constructed.The growth rate of recombinant attenuated S.entericaserovar Typhimurium SL1344ΔcrpΔasd(pYA3493-TAT-Apoptin)strain was more slowly than the SL1344 strain,but almost identical to SL1344ΔcrpΔasdstrain and SL1344ΔcrpΔasd(pYA3493)strain.The TAT-Apoptin fusion gene was inherited stably and TAT-Apoptin protein was detected in the cultured supernatant of SL1344ΔcrpΔasd(pYA3493-TAT-Apoptin)strain.These results showed that the recombinant attenuated S.enterica serovar Typhimurium SL1344ΔcrpΔasd(pYA3493-TAT-Apoptin)strain was successfully constructed and TAT-Apoptin protein was expressed in the form of secretion.
出处
《中国兽医科学》
CAS
CSCD
北大核心
2015年第6期560-566,共7页
Chinese Veterinary Science
基金
国家自然科学基金项目(31302059)
河南科技大学博士启动基金项目(4025-13480064)
关键词
减毒鼠伤寒沙门菌
凋亡素
抗肿瘤
attenuated Salmonella enterica serovar Typhimurium
apoptin
anti-tumor